Literature DB >> 9879423

Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions.

T Okamura1, J Kawabe, K Koyama, H Ochi, R Yamada, H Sakamoto, M Matsuda, Y Ohashi, Y Nakai.   

Abstract

Using X-ray CT or magnetic resonance imaging (MRI), fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) studies were performed in 28 patients with parotid lesions. All lesions except two showed higher accumulation of FDG than normal parotid gland. High accumulation was found in all of 5 carcinomas, all of 6 Warthin's tumors, and 8 of 12 pleomorphic adenomas, with standardized uptake values (SUVs) over 3.0. The mean SUVs of carcinomas, Warthin's tumors, and pleomorphic adenomas were 5.92 +/- 2.05, 7.03 +/- 2.49, and 4.07 +/- 1.55, respectively. On the other hand, all 5 inflammatory lesions demonstrated low accumulation, with mean SUVs of 1.66 +/- 0.89. It is thus difficult to differentiate malignant from benign parotid lesions by SUV on FDG-PET.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9879423     DOI: 10.1080/00016489850182954

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  8 in total

1.  Prevalence and risk of malignancy of focal incidental uptake detected by fluorine-18-fluorodeoxyglucose positron emission tomography in the parotid gland: a meta-analysis.

Authors:  Giorgio Treglia; Francesco Bertagna; Ramin Sadeghi; Barbara Muoio; Luca Giovanella
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-28       Impact factor: 2.503

2.  Incidental focal FDG uptake in the parotid glands on PET/CT in patients with head and neck malignancy.

Authors:  Young Lan Seo; Dae Young Yoon; Sora Baek; Kyoung Ja Lim; Eun Joo Yun; Young Kwon Cho; Woo Jin Bae; Eun Jae Chung; Kee Hwan Kwon
Journal:  Eur Radiol       Date:  2014-09-03       Impact factor: 5.315

Review 3.  [Salivary gland carcinomas Part II. Diagnosis and therapy].

Authors:  S Lang; N Rotter; A Lorenzen; S Ihrler; R Eckel; D Hölzel; G Rasp; B Wollenberg; K Sommer
Journal:  HNO       Date:  2005-10       Impact factor: 1.284

4.  Diagnostic Criteria on (18)F-FDG PET/CT for Differentiating Benign from Malignant Focal Hypermetabolic Lesions of Parotid Gland.

Authors:  Soo Bin Park; Joon Young Choi; Eun Jeong Lee; Jang Yoo; Miju Cheon; Suk Kyong Cho; Yearn Seong Choe; Kyung-Han Lee; Byung-Tae Kim
Journal:  Nucl Med Mol Imaging       Date:  2012-04-21

5.  Coincidence of Malignant Melanoma and an Incidently Discovered Parotid Mass Presenting a Diagnostic Challenge.

Authors:  Handan Derebaşinlioğlu; Sarper Yilmaz
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-08-07

6.  Retrospective review: usefulness of a number of imaging modalities including CT, MRI, technetium-99m pertechnetate scintigraphy, gallium-67 scintigraphy and F-18-FDG PET in the differentiation of benign from malignant parotid masses.

Authors:  Nozomi Ozawa; Terue Okamura; Koichi Koyama; Keiko Nakayama; Joji Kawabe; Susumu Shiomi; Hideo Yamane; Yuichi Inoue
Journal:  Radiat Med       Date:  2006-01

7.  Parotid incidentaloma identified by combined 18F-fluorodeoxyglucose whole-body positron emission tomography and computed tomography: findings at grayscale and power Doppler ultrasonography and ultrasound-guided fine-needle aspiration biopsy or core-needle biopsy.

Authors:  Sang Kwon Lee; Byung Hak Rho; Kyoung Sook Won
Journal:  Eur Radiol       Date:  2009-04-25       Impact factor: 5.315

Review 8.  Imaging of sinonasal tumours.

Authors:  Heidi B Eggesbø
Journal:  Cancer Imaging       Date:  2012-05-07       Impact factor: 3.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.